A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination with Insulin Aspart, in Adults with Type 1 Diabetes
RecruitingCTIS2024-519945-31-00
Novo Nordisk A/SType 1 Diabetes
Start: 2025-08-21Target: 242Updated: 2025-10-15